These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7970729)

  • 1. The capacity for growth stimulation by TGF beta 1 seen only in advanced colon cancers cannot be ascribed to mutations in APC, DCC, p53 or ras.
    Huang F; Hsu S; Yan Z; Winawer S; Friedman E
    Oncogene; 1994 Dec; 9(12):3701-6. PubMed ID: 7970729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect.
    Hsu S; Huang F; Friedman E
    J Cell Physiol; 1995 Nov; 165(2):239-45. PubMed ID: 7593201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic alterations of human colorectal cancer].
    Suzuki T; Ishioka C; Gamo M; Niitani T; Shimodaira H; Kanbe M; Yamazaki T; Yusa Y; Kanamaru R
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):343-50. PubMed ID: 8109990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
    Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
    Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
    Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
    Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A; Gold LI; Wang J; Cohen A; Friedman E
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of oncogenesis in colon versus rectal cancer.
    Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
    J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation.
    Blaydes JP; Schlumberger M; Wynford-Thomas D; Wyllie FS
    Oncogene; 1995 Jan; 10(2):307-17. PubMed ID: 7838530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence of molecular genetic events in colorectal tumorigenesis.
    Laurent-Puig P; Blons H; Cugnenc PH
    Eur J Cancer Prev; 1999 Dec; 8 Suppl 1():S39-47. PubMed ID: 10772417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
    Hsu S; Huang F; Hafez M; Winawer S; Friedman E
    Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multistep carcinogenesis in colorectal cancers.
    Takami K; Yana I; Kurahashi H; Nishisho I
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():190-6. PubMed ID: 8629105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta.
    Manning AM; Williams AC; Game SM; Paraskeva C
    Oncogene; 1991 Aug; 6(8):1471-6. PubMed ID: 1886718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
    Gemma A; Uematsu K; Hagiwara K; Takenoshita S; Kudoh S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1253-9. PubMed ID: 10945024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different genetic features associated with colon and rectal carcinogenesis.
    Frattini M; Balestra D; Suardi S; Oggionni M; Alberici P; Radice P; Costa A; Daidone MG; Leo E; Pilotti S; Bertario L; Pierotti MA
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4015-21. PubMed ID: 15217933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
    Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C
    Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.